Protease inhibitor activity in human skeletal muscle

Area of Science:

• Biochemistry
• Human Physiology
• Proteolysis

Background:

• Skeletal muscle proteolysis is implicated in catabolic states.
• Myofibrillar proteases and cytosolic inhibitors play roles in muscle protein turnover.
• Understanding their regulation is crucial for managing muscle-wasting conditions.

Purpose of the Study:

• To investigate myofibrillar protease activity and inhibitor levels in human skeletal muscle.
• To determine how acute/chronic inflammation and metastatic/nonmetastatic tumors affect these components.
• To elucidate the differential impact of catabolic conditions on muscle proteolysis.

Main Methods:

• Assessed myofibrillar protease activity in human skeletal muscle.
• Measured activity of inhibitors against trypsin, chymotrypsin, elastase, and the myofibrillar protease.
• Compared enzyme and inhibitor activities across patient groups: healthy, acute inflammation, chronic inflammation, nonmetastatic tumors, and metastatic tumors.

Main Results:

• Protease activity elevated in acute/chronic inflammation and both tumor types.
• Inhibitor activity against trypsin/chymotrypsin unaffected by acute inflammation.
• Inhibition of elastase and myofibrillar protease increased with acute inflammation.
• Chronic inflammation altered inhibitor profiles for chymotrypsin and myofibrillar protease.
• Nonmetastatic tumors increased inhibitors for trypsin, chymotrypsin, and elastase.
• Metastatic tumors showed elevated inhibitors for all tested proteases.

Conclusions:

• Myofibrillar protease activity is upregulated in catabolic states like inflammation and cancer.
• Cytosolic protease inhibitor profiles are differentially modulated by inflammation and tumor stage.
• These findings highlight distinct adaptive mechanisms in skeletal muscle proteolysis under various catabolic conditions.